MAY 10, 2018 07:30 AM PDT

Keynote Presentation: An Introduction to the All of Us Research Program

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Policy Director, All of Us Research Program, National Institutes of Health
    Biography
      Katherine D. Blizinsky, Ph.D, is the Policy Director for the All of Us Research Program. A neuroscientist and geneticist specializing in research on mental health and cognition, with a focus on health disparities, Dr. Blizinsky completed her doctoral work at Northwestern University. She is an alumna of the American Society of Human Genetics/National Human Genome Research Institute (NHGRI) Genetics and Public Policy Fellowship and has policy experience with both the legislative and executive branches. On Capitol Hill, Dr. Blizinsky worked with the Senate Health, Education, Labor, and Pensions (HELP) Committee under Ranking Member Patty Murray, where, among other roles, Dr. Blizinsky participated in the drafting and negotiation of the 21st Century Cures Act, which became law in 2016. Following her time on the Hill, she moved to NIH, where she held simultaneous appointments as Policy Advisor to the All of Us Research Program-concentrating on issues of data access, informed consent, and participant privacy-and as an Intramural Research Fellow with the NHGRI Health Disparities Unit under Vence L. Bonham. In addition to her current positions with All of Us and continued work with the Health Disparities Unit, Dr. Blizinsky is an Assistant Professor in the Department of Neurology at Rush University and on the faculty of the Rush Alzheimer's Disease Center in Chicago, IL.

    Abstract:

    The All of Us Research Program is a historic effort to gather data from one million or more people living in the United States to accelerate research and improve health. By taking into account individual differences in lifestyle, environment, and biology, researchers will uncover paths toward delivering precision medicine to all Americans. Today, we will discuss the program to date, considerations taken into account during its inception, lessons learned during the beta testing phase, and its trajectory into the future.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    JUN 29, 2018 09:00 AM PDT
    C.E. CREDITS
    JUN 29, 2018 09:00 AM PDT
    DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
    APR 25, 2018 07:00 AM PDT
    C.E. CREDITS
    APR 25, 2018 07:00 AM PDT
    DATE: April 25, 2018TIME: 1500 CET, 10:00 a.m. EST, 7:00 a.m. PST Hematology and coagulation laboratories perform a wide range of routine and specialized tests, allowing clinicians to...
    Loading Comments...